| An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia |
22 |
| Neonatal herpes simplex virus infections |
20 |
| Congenital cytomegalovirus infection |
19 |
| The United States opioid epidemic |
17 |
| Congenital syphilis |
17 |
| Recent advances in the pathogenesis of BPD |
15 |
| Current trends in neonatal ECMO |
14 |
| Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum |
14 |
| Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia |
13 |
| Modulators of inflammation in Bronchopulmonary Dysplasia |
11 |
| Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity |
11 |
| Surfactant, steroids and non-invasive ventilation in the prevention of BPD |
10 |
| An update on the diagnosis and management of bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension |
10 |
| An overview of malaria in pregnancy |
9 |
| Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia |
8 |
| Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States |
8 |
| CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations |
7 |
| An overview of medical ECMO for neonates |
7 |
| Comparative physiology of the ductus arteriosus among vertebrates |
6 |
| Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity |
6 |
| Genomics, microbiomics, proteomics, and Chock for metabolomics in bronchopulmonary dysplasia |
6 |
| The diagnosis and management of morbidly adherent placenta |
5 |
| Cardiac arrest in pregnancy |
5 |
| Prenatal genetic carrier screening in the genomic age |
5 |
| Postpartum hemorrhage: early identification challenges |
5 |
| Neuromonitoring in the neonatal ECMO patient |
5 |
| Anticoagulation in neonatal ECMO |
5 |
| Extracorporeal membrane oxygenation in infants with congenital diaphragmatic hernia |
4 |
| Neonatal abstinence syndrome |
4 |
| Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants |
4 |
| Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies |
4 |
| Epidemiology of ROP update - Africa is the new frontier |
4 |
| Abnormal placentation |
4 |
| Retinopathy of prematurity, visual and neurodevelopmental outcome, and imaging of the central nervous system |
4 |
| CRISPR in personalized medicine: Industry perspectives in gene editing |
4 |
| Role of simulation in preparation for the care of conjoined twins-prenatal preparation to separation |
4 |
| The surgical principles of conjoined twin separation |
4 |
| An update on the post-NICU discharge management Check for of bronchopulmonary dysplasia |
3 |
| Optimized protein intakes in term infants support physiological growth and promote long-term health |
3 |
| Solely human milk diets for preterm infants |
3 |
| Benefit by design: Determining the 'value' of donor human milk and medical products derived from human milk in NICU |
3 |
| Using briefing, simulation and debriefing to improve human and system performance |
3 |
| Future research directions for prevention and treatment of obstetric venous thromboembolism |
3 |
| Trends of antenatal care during pregnancy in low- and middle-income countries: Findings from the global network maternal and newborn health registry |
3 |
| CRISPR diagnostics: Underappreciated uses in perinatology |
3 |
| Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins |
3 |
| Neonatal nonpolio enterovirus and parechovirus infections |
3 |
| Adverse outcomes of pregnancy-associated Zika virus infection |
3 |
| Pharmacological treatment of opioid use disorder in pregnancy |
3 |
| Uterine factor in recurrent pregnancy loss |
3 |
